Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase Southlake, Texas, September 24, 2026 (PR NEWSWIRE) – Renibus Therapeutics® (“Renibus”), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation in the Oppenheimer Private Life Sciences Showcase, taking place virtually on September […] The post Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase appeared first on Renibus Therapeutics .